AZITRA INC AZTR

US Healthcare Pharmaceutical Preparations
$0.15
-9.6%
52w: $0.14 – $1.77

Latest 13F among current holders filed 1 month ago (May 15, 2026)

Price — last 12 months

research preview data
0.140.961.77
Jun 20, 2025 Jul 2, 2026
Institutional holders
7
-2 QoQ
13F value
$126K
+111.9% QoQ
Smart-money holders
1
signal tier ≥ 2
New smart buyers
1
Q1 2026

Institutional value by quarter

$5.3M
Q1 2024
$58K
Q2 2024
$75K
Q3 2024
$109K
Q4 2024
$161K
Q1 2025
$105K
Q2 2025
$29K
Q3 2025
$60K
Q4 2025
$126K
Q1 2026

Number of holders

13
Q1 2024
9
Q2 2024
8
Q3 2024
11
Q4 2024
12
Q1 2025
7
Q2 2025
5
Q3 2025
9
Q4 2025
7
Q1 2026

Who owns AZTR?

Q1 2026 filings
FundTypeSharesValue% of fundChange
GEODE CAPITAL MANAGEMENT, LLC Index provider469.9K$110K0.0%+505.4%
UBS Group AG Bank broker30.2K$7K0.0%+2926.6%
StoneX Group Inc. Wealth advisor22.5K$5K0.0%New
Tower Research Capital LLC (TRC) Market maker15.1K$4K0.0%+15137.4%
CITIGROUP INC Bank broker1.7K$3990.0%New
Dauntless Investment Group, LLC ★2Fundamental concentrated1.0K$2340.0%New
FMR LLC Long only active150$350.0%New

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.